TickerFactsScreenerDevelopers

HARVARD BIOSCIENCE INC (HBIO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $13.70M2009: $16.59M2010: $19.70M2011: $17.92M2012: $20.68M2013: $25.77M2014: $14.13M2015: $6.74M2016: $5.60M2017: $5.19M2018: $8.17M2019: $8.34M2020: $8.32M2021: $7.82M2022: $4.51M2023: $4.28M2024: $4.11M2025: $8.61M$8.61M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$8.61M+109.7%
2024$4.11M-4.1%
2023$4.28M-5.0%
2022$4.51M-42.4%
2021$7.82M-6.0%
2020$8.32M-0.2%
2019$8.34M+2.0%
2018$8.17M+57.4%
2017$5.19M-7.2%
2016$5.60M-17.0%
2015$6.74M-52.3%
2014$14.13M-45.2%
2013$25.77M+24.6%
2012$20.68M+15.4%
2011$17.92M-9.1%
2010$19.70M+18.8%
2009$16.59M+21.1%
2008$13.70M—